Skip to main content
Michael Recht, MD, Pediatric Hematology & Oncology, New Haven, CT, OHSU Hospital

MichaelRechtMDPhD

Pediatric Hematology & Oncology New Haven, CT

Pediatric Coagulation Disorder Hematology, Pediatric Platelet Disorder Hematology

Professor of Clinical Pediatrics, Yale University School of Medicine, New Haven, CT

Dr. Recht is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Recht's full profile

Already have an account?

Summary

  • Dr. Michael Recht is a pediatric hematologist/oncologist in New Haven, CT and is affiliated with Yale New Haven Hospital/Yale University School of Medicine. He received his medical degree from University of Wisconsin School of Medicine and Public Health and has been in practice 25 years. He specializes in pediatric coagulation disorder hematology and pediatric platelet disorder hematology and is experienced in platelet disorders, hemophilia, , and bleeding disorders. He has more than 100 publications and over 500 citings.

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Pediatric Hematology/Oncology, 1995 - 1998
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Pediatrics, 1992 - 1995
  • University of Wisconsin School of Medicine & Public Health
    University of Wisconsin School of Medicine & Public HealthClass of 1992

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2022 - 2025
  • OR State Medical License
    OR State Medical License 2007 - 2025
  • CT State Medical License
    CT State Medical License 1994 - 2024
  • AK State Medical License
    AK State Medical License 2013 - 2022
  • AZ State Medical License
    AZ State Medical License 1998 - 2009

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • One Year Data from a Phase 2b Trial of AMT-061 (AAV5-Padua hFIX variant), an Enhanced Vector for Gene Transfer in Adults with Severe or Moderate-Severe Hemophilia B
    Michael Recht, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Hemophilia Perspectives: Current Insights on the Evolution of Gene Therapy 
    60th American Society of Hematology Annual Meeting - 11/30/2018

Other

Hospital Affiliations